Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Diclofenac injection
Dihydroergotamine IV
Dimethyl fumarate	TA320 - Dimethyl fumarate for treating relapsing-remitting multiple sclerosis TA475 - Dimethyl fumarate for treating moderate to severe plaque psoriasis
Dimethyl sulphoxide bladder installation 50%
Dinoprostone
Dinoprostone (Prostin E2)
Diphenylcyclopropenone in acetone 0.00001-6.0% w/v (diphencyprone)		Unlicensed special
Disodium edetate 0.37% (EDTA)		For hospital use only
Disodium pamidronate injection
Disopyramide injection		Hospital only

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.